Company news

Proteomics International Laboratories Ltd. news in 2022

Proteomics International Laboratories Ltd.'s news releases, calls and decks from 2022, newest first.

View company

UK NICE publishes Medtech Innovation Briefing on PromarkerD

December 13, 2022

AGM Chairmans Address and Investor Presentation

November 24, 2022

PromarkerD patent granted in Hong Kong

November 10, 2022

September 2022 Quarterly Activities Report and Appendix 4C

October 30, 2022

Precision diagnostics facility receives $2m funding boost

October 19, 2022

Proteomics receives $1.7 million in R&D tax incentive

October 16, 2022

New Oesophageal Cancer Diagnostic shows strong performance

September 26, 2022

OxiDx launched to maximise oxidative stress technology

August 28, 2022

Completion of Placement and Exercise of Performance Rights

August 21, 2022

Proteomics raises $8m in highly successful Placement

August 14, 2022

Proteomics signs binding LOI with Sonic Healthcare USA

August 9, 2022

Clinical Utility Study demonstrates PromarkerD test benefits

August 1, 2022

Potential breakthrough blood test for endometriosis

July 31, 2022

June 2022 Quarterly Activities Report and Appendix 4C

July 27, 2022

European PromarkerD patents expanded beyond diabetes

July 24, 2022

Endometriosis clinical validation study readout positive

June 29, 2022

Proteomics secures licence to oesophageal cancer biomarkers

June 20, 2022

PromarkerD manufacturing tech-transfer completed

June 15, 2022

Proteomics awarded $400,000 funding to support manufacturing

May 11, 2022

March 2022 Quarterly Activities Report and Appendix 4C

April 27, 2022

New Clinical Advisory Board for PromarkerD global rollout

April 12, 2022

PromarkerD completes pre-assessment for Medicare rebate

February 21, 2022

Unique panel of biomarkers identified for oesophageal cancer

February 3, 2022

December 2021 Quarterly Activities Report and Appendix 4C

January 26, 2022

Decks in 2022